GRI
GRI Bio Inc.
NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY
$2.18
-2.25% today
Updated 2026-04-30
Market cap
$3.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-121.80
Dividend yield
—
52W range
$2 – $80
Volume
0.1M
GRI Bio Inc. (GRI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.37M | $-2.88M | $-3.71M | $-847000.00 | $-1.08M | $-8.99M | $-8.61M | $-10.19M |
| Capital expenditures | $2206.00 | $5.00 | $2000.00 | $0.00 | $3000.00 | $8000.00 | $0.00 | $3000.00 |
| Depreciation | $612.00 | $735.00 | $75000.00 | $73000.00 | $50000.00 | $57000.00 | $4000.00 | — |
| Stock-based comp | — | — | — | $0.00 | $25000.00 | $388000.00 | $148000.00 | $793000.00 |
| Free cash flow | $-2.37M | $-2.88M | $-3.71M | $-847000.00 | $-1.09M | $-9.00M | $-8.61M | $-10.19M |
| Investing cash flow | $-2204.00 | — | $-2000.00 | $-3.84M | $-3000.00 | $-8000.00 | — | — |
| Financing cash flow | $2.99M | $6.09M | $-4000.00 | $15.75M | $1.01M | $10.95M | $11.83M | — |
| Dividends paid | — | — | — | — | $3.45M | $2.92M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |